Born as a specialty oncology CRO in 2003, Medelis applys its expertise from designing and managing complex oncology clinical trials into additional therapeutic areas requiring the SOPs, training and attention to detail of a leading oncology CRO. This provides sites and our sponsors with with new research standards that deliver high-quality and clinically-relevant data and a new standard of patient safety.
Oncology trials are complex. New technologies creating cutting-edge immunotherapy treatments are promising, but add more complexity. Our clinical team has deep oncology clinical experience, providing you with an extensive array of oncology resources to support your drug in the clinic.
Read MoreMedelis is applying its expertise from designing and managing complex oncology clinical trials to the rapidly developing field of dental research, providing sites and sponsors with new research standards that deliver high-quality and clinically-relevant data and a new standard of patient safety.
Read MoreMedelis and its team have deep experience managing more than 15 nephrology studies over the past five years. As a specialty oncology CRO, our sponsors understand how our oncology expertise translates over to a broad range of kidney, urology and renal disease research and indications.
Read MoreMedelis and its team have the expertise of product development, knowledge of regulatory pathways and requirements, expansive site relationships and disciplined CRAs and PMs to handle the unique demands of medical device and diagnostics clinical trials.
Read MoreOur sponsors understand how our therapeutic expertise in neurological disorders and cutting-edge therapeutic interventions makes Medelis well-equipped to handle the complexities of CNS research.
Read More